Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

New drugs active against drug-resistant tuberculosis are urgently needed to extend the range of TB treatment options to cover drug resistant infections. Quinoxaline derivatives show very interesting biological properties (antibacterial, antiviral, anticancer, antifungal, antihelmintic, insecticidal)...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Vicente, E. (Esther), Raquel, Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Goldman, R.C. (Robert C.), Monge, A. (Antonio), Solano, B. (Beatriz), Burguete, A. (Asunción), Ancizu, S. (Saioa), Zarranz, B. (Belén), Jaso, A. (Andrés), Marin, A. (Adoración)
التنسيق: info:eu-repo/semantics/article
اللغة:eng
منشور في: Bentham Science Publishers 2011
الموضوعات:
Tuberculosis
Quinoxaline 1,4-di-N-oxide
Mycobacterium
الوصول للمادة أونلاين:https://hdl.handle.net/10171/18728

الانترنت

https://hdl.handle.net/10171/18728

مواد مشابهة